According to OpGen 's latest financial reports and stock price the company's current Operating Margin is -1,429.94%. At the end of 2021 the company had an Operating Margin of -807.28%.
Year | Operating Margin | Change |
---|---|---|
2021 | -807.28% | 30.46% |
2020 | -618.79% | 73.94% |
2019 | -355.75% | -21.59% |
2018 | -453.72% | -5.51% |
2017 | -480.20% | 0.86% |
2016 | -476.11% | -14% |
2015 | -553.60% | 302.78% |
2014 | -137.44% | -67.31% |
2013 | -420.43% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Lexicon Pharmaceuticals
LXRX | -87,620.60% | 6,027.57% | ๐บ๐ธ USA |
Enzo Biochem ENZ | -43.44% | -96.96% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.